The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDP.L Regulatory News (IDP)

  • There is currently no data for IDP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Stevie K and Charles + Lee Brands

27 Feb 2017 07:00

RNS Number : 8265X
InnovaDerma PLC
27 February 2017
 

InnovaDerma PLC

("InnovaDerma", the "Company" or the "Group")

Acquisition of Stevie K and Charles + Lee brands

InnovaDerma (LSE: IDP), a UK developer of 'at-home' and clinically proven treatments for hair loss, hair care, self-tanning and skin rejuvenation, is pleased to announce it has acquired the Intellectual Property and Assets of the 'Stevie K' and 'Charles + Lee' brands from Stevie K Cosmetics Pty Ltd and Charles + Lee Pty Ltd (the "Vendors"). Stevie K is an Australian made line of cosmetics and Charles + Lee is a range of men's skincare (the "Acquisitions").

 

In line with InnovaDerma's acquisition model, Kate Fissenden, the founder of Stevie K and Charles + Lee brands, will be incentivised as a General Manager in the Group, responsible for the growth and development of both brands. Kate has more than 10 years' experience with some of Australia's leading beauty brands and has expertise in product development and brand management. To support the success of the brands, the minimum term of Kate's employment contract with the Group is three years.

 

The purchase price for the Acquisitions is AUS$50,000 (the "Purchase Price"). The Vendors have the option to convert the Purchase Price into ordinary shares of InnovaDerma within 14 days of completion. If the Vendors exercise the Option, it will be satisfied by the issuance of approximately 39,700 ordinary shares in InnovaDerma (the exact number of shares will be calculated based on the average market price of the shares).

 

About Stevie K and Charles + Lee

 

· Stevie K is an award winning, mid-premium priced, bold range of cosmetics with strong branding and eye-catching packaging targeted at the irreverent individual in the Millennial and Generation Zero market. Founded in 2016, the brand is positioned as Australian made, cruelty free, high quality and edgy. Stevie K deliberately avoids conventional marketing channels and has strong association within the beauty and lifestyle digital platforms. It is well-suited for social media with its extensive range of striking colours and unconventional style. Announced twice as the "Best New Aussie Beauty Brand" by national print and digital media, Stevie K is currently sold online in Australia, the UK, and New Zealand. http://www.steviekcosmetics.com/

 

· Charles + Lee is an affordable alternative premium range of men's skincare, marketed as an effective and understated brand, containing natural and organic ingredients. It is cruelty free and has been certified by the Roundtable on Sustainable Palm Oil Association. The products are Australian made, currently sold online at the brand's own website and online at Urban Outfitters in Australia, New Zealand, the US, and Canada. http://charlesandlee.com

Benefits of the Acquisitions

The Company has previously stated its intention to acquire brands which are ready to market and complementary to its existing portfolio. There are significant opportunities for a number of commercial, operational and financial synergies, which are expected to create value for InnovaDerma's shareholders:

· Stevie K and Charles + Lee are highly differentiated, innovative brands and provide the Company with entry into the alternative premium end of the make-up and men's skincare market;

· There is existing and growing demand for high quality make-up and men's skincare which is ethical, natural and alternative. These concepts fit with the international perception of Australian lifestyle, and therefore the Company will seek to harness these as part of its marketing strategy;

· Both brands are well-suited for social media and have already developed a strong following which is key to driving brand loyalty and revenue;

· The current geographic footprint of the Acquisitions fits well with the Company's established presence in Australia, UK and the US;

· With InnovaDerma's strong distribution network in nine countries and a growing Direct-to-Consumer ("DTC") Platform with proven social media campaigns, the Board believes there is an opportunity to grow revenues of the Acquisitions by accessing these home-grown channels;

· The Board does not envisage significant integration costs arising from the Acquisitions;

· The Company expects the Acquisitions to be revenue and earnings enhancing from the last quarter of the financial year.

Haris Chaudhry, Executive Chairman of InnovaDerma said:

"Stevie K and Charles + Lee are an excellent strategic fit for InnovaDerma and we are pleased to have acquired such highly differentiated brands which the Board believes will bring considerable international growth opportunities. We welcome Kate Fissenden to the Company and look forward to working with her to drive profitable growth in the future."

Further enquiries:

InnovaDerma

Haris Chaudhry/Joe Bayer

 

+61 (0)3 9111 0071

Sole broker

Hybridan LLP

Claire Noyce

 

+44 (0)203 764 2341

Cardew Group

Shan Shan Willenbrock

David Roach

Emma Ruttle

 

+ 44 (0)20 7930 0777

 

About InnovaDerma:

InnovaDerma PLC (LSE: IDP) specializes in the research, manufacture and marketing of clinically proven products in life sciences, beauty and personal care products. InnovaDerma has presence in the UK, US, Australia, New Zealand, Philippines, South Africa, Hong Kong and South Korea.

 

www.innovaderma.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQSEUFDLFWSEDE
Date   Source Headline
8th Mar 201810:13 amRNSTrading Statement
15th Feb 20187:00 amRNSHalf-year Report
2nd Feb 20187:00 amRNSDirector/PDMR Shareholding
16th Jan 20187:00 amRNSTrading Statement
15th Dec 20177:00 amRNSIssue of Warrants and Issue of Equity
24th Nov 201711:37 amRNSHolding(s) in Company
10th Nov 20177:00 amRNSAllotment of Shares
8th Nov 201710:47 amRNSResult of AGM
8th Nov 20177:00 amRNSAGM Statement and Operational Update
7th Nov 20178:16 amRNSHolding(s) in Company
20th Oct 20177:53 amRNSAllotment of Shares
18th Oct 20179:52 amRNSASA Ruling
16th Oct 20177:00 amRNSHolding(s) in Company
16th Oct 20177:00 amRNSAdmission of Shares
12th Oct 20175:18 pmRNSNotice of AGM & Posting of Annual Report
12th Oct 201710:40 amRNSHolding(s) in Company
9th Oct 20177:00 amRNSTotal Voting Rights
6th Oct 20179:55 amRNSCompletion of Placing
6th Oct 20177:00 amRNSProposed Placing
2nd Oct 20177:00 amRNSAllotment of Shares
27th Sep 20177:00 amRNSOperational Update
14th Sep 20177:00 amRNSTransfer of Shares
12th Sep 20177:00 amRNSFinal Results
4th Sep 20177:00 amRNSOperational Update
11th Aug 20179:30 amRNSNotice of Results
28th Jul 201711:58 amRNSDirector/PDMR Shareholding
26th Jul 20172:22 pmRNSAllotment of Shares
26th Jul 20177:00 amRNSOperational Update
26th Jul 20177:00 amRNSDirectorate Change and Change Of Adviser
19th Jun 20174:40 pmRNSSecond Price Monitoring Extn
19th Jun 20174:35 pmRNSPrice Monitoring Extension
19th Jun 20172:05 pmRNSSecond Price Monitoring Extn
19th Jun 20172:00 pmRNSPrice Monitoring Extension
19th Jun 201711:05 amRNSSecond Price Monitoring Extn
19th Jun 201711:00 amRNSPrice Monitoring Extension
19th Jun 20179:05 amRNSSecond Price Monitoring Extn
19th Jun 20179:00 amRNSPrice Monitoring Extension
19th Jun 20178:18 amRNSTrading Statement (Replacement)
19th Jun 20177:00 amRNSTrading Statement
8th Jun 20177:00 amRNSExercise of Broker Warrants
1st Jun 20177:00 amRNSInnovaDerma secures Boots Ireland
22nd May 20172:05 pmRNSSecond Price Monitoring Extn
22nd May 20172:00 pmRNSPrice Monitoring Extension
22nd May 20177:00 amRNSLaunch of haircare range and entry into skincare
15th May 20179:47 amRNSHolding(s) in Company
10th May 20172:25 pmRNSHolding(s) in Company
10th May 20172:21 pmRNSHolding(s) in Company
8th May 20173:54 pmRNSAllotment of Shares
5th May 20174:40 pmRNSSecond Price Monitoring Extn
5th May 20174:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.